Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Southeast Asian J Trop Med Public Health ; 2004 Mar; 35(1): 172-4
Artigo em Inglês | IMSEAR | ID: sea-33444

RESUMO

To study the efficacy of the combination of albendazole and prednisolone for the treatment of eosinophilic meningitis, we conducted a pilot study among Thai patients with eosinophilic meningitis. Patients were given a 2-week course of prednisolone, 60 mg/day and albendazole, 15 mg/kg/ day. The primary observation parameter was the number of patients who still had headache after the 2-week course of treatment. Twenty-six patients were enrolled in the study. There were 3 (11.5%) patients who still had headache after the 2-week course of treatment and the median length of time until complete disappearance of headache was 4 days. Serious side effects were not detected. Treatment for 2 weeks with the combination regimen of albendazole and prednisolone is safe and effective for the treatment of eosinophilic meningitis.


Assuntos
Administração Oral , Adolescente , Adulto , Albendazol/administração & dosagem , Relação Dose-Resposta a Droga , Esquema de Medicação , Quimioterapia Combinada , Eosinofilia/diagnóstico , Feminino , Seguimentos , Humanos , Masculino , Meningite Asséptica/diagnóstico , Pessoa de Meia-Idade , Prednisolona/administração & dosagem , Estudos Prospectivos , Medição de Risco , Índice de Gravidade de Doença , Tailândia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA